AU2005291993B2

Biomedical devices containing amphiphilic block copolymers

Abstract

This invention relates to wettable biomedical devices comprising amphiphilic block copolymers. The amphiphilic block copolymers are useful as internal wetting agents for biomedical applications, such as implantable devices, ophthalmic devices and in one embodiment, contact lenses.

AU2005291993B2, drawing sheet 1
Sheet 1 of 4

Term

Term ended

Expired 28 September 2025, 1 year ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

39 claims: 20 independent, 19 dependent

  1. 1
    The claims defining the invention are as follows:1. A silicone hydrogel comprising the reaction product of a reaction mixture comprising at least one silicone containing component;at least one substantially non5 polymerizible amphiphilic block copolymer;and at least one hydrophilic component.
  2. 5
    The hydrogel of any one of claims 1 to 4 ,wherein said amphiphilic block copolymer has weight average molecular weight of at least 100,000.
  3. 8
    The hydrogel of any one of claims 1 to 7, wherein said amphiphilic copolymer comprises 1 to 20 weight% hydrophobic segments and 80 to 99 weight% 20 hydrophilic segments.
  4. 13
    The hydrogel of any one of claims 8 to 12, wherein said hydrophobic segments are derived from hydrophobic polymers selected from the group consisting 10 of linear polydimethylsiloxanes with terminal reactive groups.
  5. 14
    The hydrogel of any one of claims 8 to 12, wherein said hydrophobic segments are derived from hydrophobic polymers formed from monomers selected from the group consisting of octamethylcyclotetrasiloxane;1,3-bisaminopropyltetramethyldisiloxane;1,3-bis-hydroxypropyltetramethyldisiloxane;
  6. 15
    15 dichlorodimethylsilane, 1,1,3,3-tetramethyldisiloxane;4,4-azobis(4-cyanovaleric acid);toluenediisocyanate, isophoronediisocyanate;1,3-bisvinyltetramethyldisiloxane;3-methacryloxypropyltris(trimethylsiloxy)silane;pentamethyldisiloxanyl methylmethacrylate;and methyldi(trimethylsiloxy)methacryloxymethyl silane;monomethacryloxypropyl 20 terminated mono-n-butyl terminated polydimethylsiloxane;3[tris(trimethylsiloxy)silyl] propyl allyl carbamate;3-[tris(trimethylsiloxy)silyl] propyl vinyl carbamate;trimethylsilylethy 1 vinyl carbonate;trimethylsilylmethyl vinyl carbonate;and 2-propenoic acid, 2-methyl-2-hydroxy-3- [3-(1,3,3,3tetramethyl-1 - [trimethylsilyloxy]disiloxanyl]propoxy] propyl ester and 25 combinations thereof. 15. The hydrogel of any one of claims 1 to 14, wherein the amphiphilic block copolymer is derived from poly-N-vinylpyrrolidone and poly(dimethylsiloxane) segments.
  7. 16
    The hydrogel of any one of claims 1 to 15, wherein said silicone 30 containing component is present in an amount between 5 percent to 75 percent, based upon all reactive components.
  8. 17
    17/06/11 ,ck 16470spcciclaims.doc,35 -362005291993 20 Jun2011 17. The hydrogel of claim 16 wherein the silicone containing component is present in an amount between 10 percent to 50 percent, based upon all reactive components.
  9. 18
    The hydrogel of any one of claims 1 to 17, wherein said at least one 5 silicone containing component is selected from the group consisting of silicone containing monomers, silicone containing macromers and mixtures thereof.
  10. 19
    The hydrogel of any one of claims 1 to 17, wherein said at least one silicone containing component is selected from the group consisting of polysiloxyalkyl(meth)acrylic monomers, poly(organosiloxane) prepolymers, silicone 10 containing vinyl carbonate monomers, silicone containing vinyl carbamate monomers, and mixtures thereof.
  11. 20
    The hydrogel of any one of claims 1 to 17, wherein said at least one silicone containing component is selected from the group consisting of α, ωbismethacryloxypropyl poly-dimethylsiloxane, monomethacryloxypropyl terminated 15 mono-n-butyl terminated polydimethyisiloxane, methacryloxypropyl tris(trimethylsiloxy)silane and combinations thereof.
  12. 21
    The hydrogel of any one of claims 1 to 20, wherein said hydrophilic component is selected from the group consisting of acrylic containing monomers, hydrophilic vinyl-containing monomers, hydrophilic vinyl carbonate or vinyl 20 carbamate monomers, polyoxyethylene polyols and combinations thereof.
  13. 22
    The hydrogel of any one of claims 1 to 20, wherein said hydrophilic component is selected from the group consisting of Ν,Ν-dimethylacrylamide (DMA), 2-hydroxyethyl acrylate , glycerol methacrylate, 2-hydroxyethyl methacrylamide, polyethyleneglycol monomethacrylate, methacrylic acid, acrylic acid, N-vinyi 25 pyrrolidone, N-vinyl-N-methyl acetamide, N-vinyl-N-ethyl acetamide, N-vinyl-Nethyl formamide, N-vinyl formamide, N-2-hydroxyethyl vinyl carbamate, Ncarboxy-B-alanine N-vinyl ester, reactive polyethylene polyols, ydrophilic vinyl carbonates, vinyl carbamate monomers, hydrophilic oxazolone monomers, hydrophilic oxazoline monomers and combinations thereof. 30
  14. 23
    The hydrogel of any one of claims 1 to 20, wherein said hydrophilic component is selected from the group consisting of Ν,Ν-dimethyl acrylamide, 2hydroxyethyl acrylate, 2-hydroxyethyl methacrylate, glycerol methacrylate, 217/06/11 ,ck 16470speciclai ms. doc.36 -372005291993 20 Jun2011 hydroxyethyl methacrylamide, N-vinylpyrrolidone, polyethyleneglycol monomethacrylate and combinations thereof.
  15. 24
    The hydrogel of any one of claims 1 to 20, wherein said hydrophilic component is selected from the group consisting of Ν,Ν-dimethylacrylamide, N5 vinylpyrrolidone and mixtures thereof.
  16. 25
    The hydrogel of any one of claims 1 to 24, wherein said at least one hydrophilic component is present in amounts up to 70 weight percent.
  17. 28
    The hydrogel of any one of claims 1 to 27, wherein said reaction mixture further comprises at least one compatibilizing component in amounts up to 90 weight percent. 15
  18. 33
    A biomedical device comprising the hydrogel of any one of claims 1 to 10 32.
  19. 34
    An ophthalmic device comprising the hydrogel of any one of claims 1 to 32.
  20. 35
    A contact lens comprising the hydrogel of any one of claims 1 to 32.
  21. 36
    A method comprising the steps of (a) mixing a low molecular weight, 15 substantially non-polymerizible amphiphilic polymer and reactive components comprising at least one silicone containing component and at least one hydrophilic component, (b) curing the product of step (a) in a mold to form a biomedical device and (c) deblocking said ophthalmic device from said mold.
Independent claims21